NCT07366281 Post-operative Use of New Adhesive After Total Laryngectomy
| NCT ID | NCT07366281 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Atos Medical AB |
| Condition | Laryngectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2026-08-30 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2026-08-30 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the feasibility, safety, and performance of the new adhesive when used in the immediate post-operative period after total laryngectomy. The main question it aims to answer is: \- Is the adhesive feasible and safe to use during the early post-operative phase? This is a single-arm feasibility study with historical controls, so there is no concurrent comparison group. Researchers will compare outcomes to historical data from standard adhesive use to assess improvements in tolerance and skin condition. Participants will: * Use the adhesive as part of their standard post-laryngectomy care. * Complete patient-reported outcome questionnaires (e.g., comfort, skin assessment, satisfaction). * Allow investigators to record observations in diaries and patient charts. * Participate in routine clinical assessments during hospitalization and at end of study (approximately 30 days post-surgery).
Eligibility Criteria
Inclusion Criteria: * Patient undergoing total laryngectomy surgery * 18 years or older Exclusion Criteria: * Unable to give informed consent prior to TL surgery
Frequently Asked Questions
Who can join the NCT07366281 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Laryngectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07366281 currently recruiting?
Yes, NCT07366281 is actively recruiting participants. Visit ClinicalTrials.gov or contact Atos Medical AB to inquire about joining.
Where is the NCT07366281 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands, Groningen, Netherlands, Maastricht, Netherlands.
Who is sponsoring the NCT07366281 clinical trial?
NCT07366281 is sponsored by Atos Medical AB. The trial plans to enroll 25 participants.